Total Payments
$5,355
2024 Payments
$1,036
Companies
42
Transactions
307
Medicare Patients
1,833
Medicare Billing
$212,596
Payment Breakdown by Category
Food & Beverage$5,107 (95.4%)
Education$248.41 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,107 | 302 | 95.4% |
| Education | $248.41 | 5 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $991.59 | 42 | $0 (2024) |
| PFIZER INC. | $962.49 | 87 | $0 (2024) |
| GENZYME CORPORATION | $261.07 | 12 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $253.41 | 13 | $0 (2023) |
| Seagen Inc. | $239.44 | 8 | $0 (2023) |
| ARRAY BIOPHARMA INC | $220.95 | 11 | $0 (2024) |
| Genentech USA, Inc. | $193.22 | 13 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $182.54 | 10 | $0 (2021) |
| Merck Sharp & Dohme LLC | $170.14 | 9 | $0 (2024) |
| Amgen Inc. | $168.56 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,036 | 57 | PFIZER INC. ($269.36) |
| 2023 | $1,319 | 60 | Janssen Biotech, Inc. ($376.68) |
| 2022 | $86.54 | 4 | PFIZER INC. ($37.34) |
| 2021 | $401.61 | 20 | Janssen Biotech, Inc. ($75.93) |
| 2020 | $608.69 | 34 | Janssen Biotech, Inc. ($99.15) |
| 2019 | $1,298 | 85 | PFIZER INC. ($282.09) |
| 2018 | $458.34 | 37 | PFIZER INC. ($114.88) |
| 2017 | $146.93 | 10 | Genentech USA, Inc. ($43.70) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 08/06/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: GENETIC DISEASE | ||||||
| 07/30/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: GENETIC DISEASE | ||||||
| 07/16/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Oncology | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $25.68 | General |
| Category: Hematology | ||||||
| 06/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.46 | General |
| 05/15/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 427 | 678 | $181,316 | $46,982 |
| 2022 | 7 | 411 | 713 | $189,589 | $48,395 |
| 2021 | 9 | 507 | 908 | $251,048 | $64,045 |
| 2020 | 8 | 488 | 936 | $232,838 | $53,174 |
Total Patients
1,833
Total Services
3,235
Medicare Billing
$212,596
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 241 | $72,059 | $18,978 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 357 | $68,901 | $18,410 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $14,586 | $3,921 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $15,210 | $3,248 | 21.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $10,560 | $2,425 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 207 | 383 | $73,919 | $19,922 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 211 | $63,089 | $16,245 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 30 | $12,870 | $3,641 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $11,154 | $2,508 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $11,745 | $2,476 | 21.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 32 | $8,832 | $1,898 | 21.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 20 | $7,980 | $1,705 | 21.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 289 | $86,411 | $23,075 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 233 | 433 | $83,569 | $22,837 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 64 | $17,664 | $3,855 | 21.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 25 | $10,725 | $2,978 | 27.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 25 | $13,250 | $2,749 | 20.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $12,675 | $2,617 | 20.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $8,580 | $2,016 | 23.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $9,396 | $2,015 | 21.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 22 | $8,778 | $1,902 | 21.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 255 | 501 | $96,693 | $21,828 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 315 | $94,185 | $21,122 | 22.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 39 | $16,731 | $3,720 | 22.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $7,920 | $1,732 | 21.9% |
About Dr. Steven Weiss, M.D
Dr. Steven Weiss, M.D is a Specialist healthcare provider based in Coral Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730185299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Weiss, M.D has received a total of $5,355 in payments from pharmaceutical and medical device companies, with $1,036 received in 2024. These payments were reported across 307 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,107).
As a Medicare-enrolled provider, Weiss has provided services to 1,833 Medicare beneficiaries, totaling 3,235 services with total Medicare billing of $212,596. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Coral Springs, FL
- Active Since 06/21/2005
- Last Updated 07/14/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1730185299
Products in Payments
- ERLEADA (Drug) $418.32
- DARZALEX (Biological) $314.04
- IBRANCE (Drug) $250.49
- XTANDI (Drug) $212.62
- VPRIV (Biological) $174.10
- KEYTRUDA (Biological) $170.14
- IMBRUVICA (Drug) $164.33
- BOSULIF (Drug) $137.73
- LORBRENA (Drug) $136.12
- CERDELGA (Drug) $104.36
- INLYTA (Drug) $100.56
- Enhertu (Drug) $95.83
- OPDIVO (Biological) $93.89
- ELIQUIS (Drug) $92.41
- XALKORI (Drug) $90.41
- TUKYSA (Drug) $86.26
- Lenvima (Drug) $82.64
- CYRAMZA (Drug) $78.80
- LUTATHERA (Drug) $73.35
- GAZYVA (Biological) $72.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Coral Springs
Dr. Neal Weinreb, M.d, M.D
Specialist — Payments: $335,680
Specialist $335,680
Jose Vindas Cordero, Md, MD
Specialist — Payments: $47,450
Specialist $47,450
Dr. Vivian Rose, M.d, M.D
Specialist — Payments: $21,530
Specialist $21,530
Dr. Michael Zahalsky, M.d., P.a, M.D., P.A
Specialist — Payments: $21,285
Specialist $21,285
Dawn Scarzella, M.d, M.D
Specialist — Payments: $12,373
Specialist $12,373
Dr. Nesreen Kurtom, D.o, D.O
Specialist — Payments: $6,590
Specialist $6,590